---
title: "Does Testosterone Cause Heart Attacks? The FDA's Reversal"
description: "Learn the truth behind the testosterone black box warning, what the latest science reveals, and why fear shouldn't hold you back. Call us."
url: "https://crhormonehealth.com/blog/testosterone-black-box-warning/"
---

# Does Testosterone Cause Heart Attacks? The FDA’s Reversal

![A smiling man with short dark hair and a neatly trimmed beard, wearing a black collared shirt, stands in front of a plain, neutral background.](https://crhormonehealth.com/wp-content/uploads/Matthew-Stolzman-author-pic-150x150.jpg) 

Updated on June 16, 2026 by [Matthew Stolzman](#author-bio)

Medically Reviewed By: **[Dr. Lee Moorer](/about/dr-lee-moorer/ "Dr. Lee Moorer")**

Share this article! 

[ ](https://www.facebook.com/sharer/sharer.php?u=https://crhormonehealth.com/blog/testosterone-black-box-warning/) [ ](https://twitter.com/intent/tweet?url=https://crhormonehealth.com/blog/testosterone-black-box-warning/) [ ](https://www.linkedin.com/sharing/share-offsite/?url=https://crhormonehealth.com/blog/testosterone-black-box-warning/) [ ](https://wa.me/?text=https://crhormonehealth.com/blog/testosterone-black-box-warning/) [ ](/cdn-cgi/l/email-protection#28175b5d4a424d4b5c156b404d4b43085c40415b08475d5c0e4a474c5115405c5c585b1207074b5a40475a4547464d404d49445c40064b4745074a44474f075c4d5b5c475b5c4d5a47464d054a44494b43054a4750055f495a4641464f07) 

![Does Testosterone Cause Heart Attacks-The FDAs Reversal](https://crhormonehealth.com/wp-content/uploads/Does-Testosterone-Cause-Heart-Attacks-The-FDAs-Reversal.png) 

### Table of contents

## **Key Takeaways**

1. No, testosterone therapy does not cause heart attacks.
2. In February 2025, the FDA removed the black box warning linking testosterone products to heart risk, replacing it with a more specific caution around blood pressure monitoring.
3. At Castle Rock Hormone Health, patients receive quarterly lab monitoring and [personalized care](https://crhormonehealth.com/men/hormone-optimization/) to keep [testosterone therapy](https://crhormonehealth.com/women/hormone-optimization/) safe and effective.

## **How Does the FDA Black Box Warning Relate to Hormone Optimization**

For over a decade, every testosterone product in the United States carried a black box warning. This is the FDA’s most serious safety label. It stated that testosterone therapy may increase the risk of heart attack and stroke.

That single warning changed how millions of men and women thought about [hormone health](https://crhormonehealth.com/blog/personalized-hormone-optimization-castle-rock/). Prescribing rates dropped. Conversations shifted from “How do we optimize your health?” to “Is this even safe?”

People who could have benefited from treatment were left untreated. They lived with fatigue, brain fog, low drive, and shrinking muscle mass because no one wanted to risk it.

Some were told to try lifestyle changes alone. Others were put on antidepressants or sleep medications for problems that may have been hormonal all along.

The problem? That warning was built on shaky ground.

## **Where Did the Heart Concern Come From?**

The basis for the FDA black box warning cameIt came from a handful of smaller, lower-quality studies published between 2010 and 2014, many of which had serious design flaws. The fear that testosterone therapy might hurt the heart didn’t come from a single, clear-cut study. 

One of the most cited was the[ TOM trial](https://www.nejm.org/doi/full/10.1056/NEJMoa1000485) in 2010\. It was stopped early after a small number of older men with multiple health problems experienced heart-related events while on testosterone. 

The study only included 209 men. Most had severe physical limitations and chronic illnesses. It was never designed to measure heart outcomes.

Another was a 2013 study that looked back at VA medical records and initially reported higher rates of heart attack and stroke among men prescribed testosterone. That study was later corrected after researchers found errors in the data.

Despite these problems, the FDA took action. In 2014, the agency issued a[ safety warning](https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-evaluating-risk-stroke-heart-attack-and-death-fda-approved) about heart risk with testosterone products. By 2015, a[ black box warning was added](https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-cautions-about-using-testosterone-products-low-testosterone-due) to all testosterone products, and manufacturers were told to fund a large-scale study to settle the question once and for all.

That study became TRAVERSE.

But by then, the damage was done. Doctors became hesitant to prescribe testosterone even to patients who clearly needed it. Patients who had been doing well on therapy were taken off it. 

An entire generation of men and women with low hormone levels were told to wait, based on evidence that would later fall apart.

## **What the TRAVERSE Trial Actually Found**

The[ TRAVERSE trial](https://clinicaltrials.gov/study/NCT03518034) is the largest and most rigorous study ever done on testosterone and heart safety. Here’s what made it gold standard:

* It enrolled 5,246 men between the ages of 45 and 80 with confirmed [low testosterone](https://crhormonehealth.com/blog/low-testosterone-at-20/).
* All participants already had heart disease or were at high risk for it.
* Participants were randomly given either testosterone gel or a placebo.
* Neither the doctors nor the patients knew who received which one.
* Researchers followed them for an average of nearly three years.

The result: no meaningful difference between the placebo and testosterone group. About 7.0% of men on testosterone had a major heart event, compared to 7.3% on the placebo. In plain terms, the **men taking testosterone fared just as well as the men who weren’t.**

The findings were published in the[ _New England Journal of Medicine_](https://pubmed.ncbi.nlm.nih.gov/37326322/) in 2023, one of the most respected medical journals in the world. The study’s investigators pointed out that TRAVERSE tracked more heart events than every previous testosterone study combined. It is by far the most reliable answer we’ve ever had.

The trial also found no increase in prostate cancer or prostate-related problems.

It did, however, find slightly higher rates of irregular heartbeat (specifically a type called atrial fibrillation), blood clots, and kidney issues in the testosterone group. 

These findings are now reflected in updated product labels. They are also exactly the kind of things that proper monitoring catches early.

## **What the FDA Did in February 2025**

Based mainly on the TRAVERSE results and additional blood pressure monitoring studies, the[ FDA updated the labels](https://www.fda.gov/drugs/drug-safety-and-availability/fda-issues-class-wide-labeling-changes-testosterone-products) on all testosterone products on February 28, 2025\. The key changes included:

* Removing the black box warning about heart attack and stroke risk from all testosterone products.
* Adding the TRAVERSE trial results to all testosterone product labels so doctors and patients can see the actual data.
* Adding a new warning about blood pressure, because separate studies confirmed that testosterone products can raise blood pressure in some men.
* Keeping the existing limits on who can be prescribed testosterone, the FDA still only approves it for men with a medical condition causing low testosterone, not just age-related decline.

This wasn’t a minor tweak. The FDA was acknowledging that the original heart warning, while understandable given the limited data in 2015, wasn’t backed by strong science.

For patients considering hormone optimization, this means the conversation with your provider no longer needs to start with fear. It can start with the question that actually matters: what are your symptoms, and what do your labs say? That is a better starting point for everyone involved.

## **What This Means If You’ve Been Avoiding Testosterone Therapy**

If you’ve been holding off on treatment because of heart concerns, this changes the conversation. Here’s what the old warning may have cost you:

### What if the Studies Behind the Warning Were Outdated?

The studies that triggered the original warning were small, poorly designed, and later corrected. One enrolled just 209 men. Another had to issue a data correction after publication. Neither was built to measure heart outcomes as a main goal.

The TRAVERSE trial enrolled over 5,200 participants. It followed them for nearly three years. It found no increased heart risk. You were worried about something that the best available science does not support.

### How Long Have You Been Living With Symptoms You Didn’t Have To?

Every year spent avoiding testosterone therapy because of an inaccurate warning is a year of living with symptoms that didn’t need to be there. Low energy, brain fog, poor sleep, declining strength. 

These aren’t just inconveniences. They affect your work, your relationships, and your quality of life.

Think about what that looks like day to day. You skip the gym because you are too tired. You lose patience with your partner because your mood is off. You cannot focus at work the way you used to. You chalk it up to aging or stress. But the real issue might be something a simple blood test could catch.

The longer these symptoms go unaddressed, the harder they are to reverse. Muscle loss leads to weight gain. Poor sleep leads to worse energy. One problem feeds another. Getting tested early can break that cycle before it takes hold.

![A smiling bald man in a suit stands next to text that reads: 10 Signs of Low Testosterone Men Ignore \(Until They Can’t\) with attribution to Chris Stolzman. The background is light yellow with a blue border, raising the question: Does hormone therapy cause breast cancer?.]() 

## 10 Signs of Low Testosterone Men Ignore (Until They Can’t)

Struggling with fatigue, low drive, or brain fog? Discover low testosterone symptoms in men that usually get ignored.

[Learn More ](https://crhormonehealth.com/blog/low-testosterone-symptoms-in-men/) 

### What Does Proper Testosterone Therapy Actually Look Like?

The men in the TRAVERSE trial had their levels checked regularly. Doses were adjusted to keep them in a healthy range. They had ongoing follow-up visits and blood work. Under that kind of care, there was no increased heart risk — and many experienced real improvements.

This is exactly the kind of care Castle Rock Hormone Health provides. As [Dr. Kelli Weiner](https://crhormonehealth.com/about/dr-kelli-weiner/) explains:

“We’re always checking labs every three months to make sure we’re right where we want to be and also checking in with the patients, making sure they’re still feeling really good.”

The clinic includes all lab work in the cost of the program. [Dr. Lee Moorer](https://crhormonehealth.com/about/dr-lee-moorer/) is direct about why:

“We roll in the cost of laboratory values and medicines. If you need labs more often than every three months, it’s just part of the program. And we eat that cost.”

## What Should You Do Next?

The black box warning is gone. The science is clear. If you’ve been putting off testosterone therapy because of outdated heart concerns, here’s how to move forward:

1. Get a full hormone panel. Not just total testosterone. A single number doesn’t tell the whole story.
2. Find a provider who monitors you the right way. The TRAVERSE trial proved testosterone is safe when levels are tracked and doses are adjusted regularly. That means quarterly lab work, not a prescription and a handshake.
3. [Schedule a free evaluation](https://crhormonehealth.com/) with Castle Rock Hormone Health. Get a symptom-based assessment from providers who check your hormones, blood pressure, and heart health markers at every visit. Adjust your plan when something changes.

  
\*\*_This article has been reviewed by qualified medical professionals for accuracy, but it is intended for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or another qualified healthcare provider with any questions about a medical condition or symptoms. Never disregard or delay seeking professional advice based on information read here._ 

## **FAQs**

### **Can high testosterone cause heart problems?**

Yes, if levels go too high. Testosterone levels significantly above the normal range can thicken the blood, raise blood pressure, and disrupt cholesterol levels. But that’s not what medical hormone therapy does. The TRAVERSE trial, the largest cardiovascular safety trial on testosterone to date, found no increase in heart attacks or strokes in men on properly managed therapy.  
The difference is in monitoring. At Castle Rock Hormone Health, labs are checked every three months. If something like rising hematocrit or estrogen conversion shows up, the dose gets corrected before it becomes a problem.  
The goal is never to push levels as high as possible. It is to find the range where you feel your best and stay safe.

### **Is testosterone safe for heart patients?**

Yes, for men with confirmed low testosterone, as long as they’re being closely watched. The TRAVERSE trial[ enrolled men](https://www.cedars-sinai.org/stories-and-insights/healthy-living/research-finds-testosterone-therapy-safe-for-heart-health) who already had heart disease or were at high risk for it, and still found no increase in heart attacks, strokes, or heart-related deaths compared to the placebo group.   
The study did find slightly higher rates of irregular heartbeat and blood clots. This is why Castle Rock Hormone Health monitors blood pressure, blood counts, and heart health markers at every check-in. Each visit adjusts treatment the moment something looks off.

### **Does low testosterone increase heart disease risk?**

Growing research suggests it might. Several large population studies have found that men with low testosterone are more likely to develop conditions closely tied to heart disease, including type 2 diabetes, obesity, and a cluster of risk factors doctors call metabolic syndrome.   
A 2017 review in the[ _Methodist DeBakey Cardiovascular Journal_](https://pmc.ncbi.nlm.nih.gov/articles/PMC5512682/) found that low testosterone in men with heart failure was linked to worse outcomes and higher death rates, and that low levels may raise the risk of blocked arteries on their own.   
This doesn’t necessarily mean low testosterone directly causes heart disease. But it does suggest that ignoring low testosterone could mean overlooking a bigger health picture.  
This is why Castle Rock Hormone Health does not stop at testosterone. Every patient gets a full hormone panel, metabolic markers, and a provider who looks 

<!-- truncated -->